HK1092871A1 - 先兆子癇的篩查 - Google Patents

先兆子癇的篩查

Info

Publication number
HK1092871A1
HK1092871A1 HK06113515.3A HK06113515A HK1092871A1 HK 1092871 A1 HK1092871 A1 HK 1092871A1 HK 06113515 A HK06113515 A HK 06113515A HK 1092871 A1 HK1092871 A1 HK 1092871A1
Authority
HK
Hong Kong
Prior art keywords
preeclampsia
screening
Prior art date
Application number
HK06113515.3A
Other languages
English (en)
Inventor
Thadhani Ravi
S Karumanchi Ananth
Original Assignee
總醫院公司
貝斯以色列女執事醫療中心
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 總醫院公司, 貝斯以色列女執事醫療中心 filed Critical 總醫院公司
Publication of HK1092871A1 publication Critical patent/HK1092871A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/321—Arterial hypertension
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/809—Multifield plates or multicontainer arrays

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK06113515.3A 2003-09-23 2006-12-07 先兆子癇的篩查 HK1092871A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50570703P 2003-09-23 2003-09-23
PCT/US2004/031268 WO2005031364A1 (en) 2003-09-23 2004-09-23 Screening for gestational disorders

Publications (1)

Publication Number Publication Date
HK1092871A1 true HK1092871A1 (zh) 2007-02-16

Family

ID=34393058

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06113515.3A HK1092871A1 (zh) 2003-09-23 2006-12-07 先兆子癇的篩查

Country Status (8)

Country Link
US (2) US7344892B2 (zh)
EP (1) EP1664797B1 (zh)
JP (1) JP4568282B2 (zh)
AU (1) AU2004276791B2 (zh)
CA (1) CA2539430C (zh)
ES (1) ES2556164T3 (zh)
HK (1) HK1092871A1 (zh)
WO (1) WO2005031364A1 (zh)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7435419B2 (en) * 2002-07-19 2008-10-14 Beth Israel Deaconess Medical Center Methods of diagnosing and treating pre-eclampsia or eclampsia
ES2534926T3 (es) * 2002-07-19 2015-04-30 Beth Israel Deaconess Medical Center Métodos para tratar la preeclampsia
US7335362B2 (en) 2002-07-19 2008-02-26 Beth Israel Deaconess Medical Center Methods of treating pre-eclampsia or eclampsia
US8068990B2 (en) * 2003-03-25 2011-11-29 Hologic, Inc. Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
US7191068B2 (en) * 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
WO2005019792A2 (en) 2003-08-21 2005-03-03 Mcgill University Method and apparatus for analyzing amniotic fluid
AU2005244167A1 (en) * 2004-05-04 2005-11-24 Beth Israel Deaconess Medical Center Methods and compositions for treatment of preeclampsia
MX2007002100A (es) * 2004-08-21 2007-04-26 Univ Mcgill Metodo y aparato para analizar fluido amniotico.
US7740849B2 (en) * 2004-09-24 2010-06-22 Beth Israel Deaconess Medical Center Use of compounds that bind soluble endoglin and SFLT-1 for the treatment of pregnancy related hypertensive disorders
DE602005024850D1 (de) * 2004-09-24 2010-12-30 Beth Israel Hospital Verfahren zur diagnose und behandlung von schwangerschaftsskomplikationen
DE102004051847B4 (de) 2004-10-25 2008-09-18 Dade Behring Marburg Gmbh Verhältnis von PIGF und Flt-1 als prognostischer Parameter bei kardio-vaskulären Erkrankungen
CN101299962A (zh) * 2004-12-15 2008-11-05 貝丝以色列女执事医疗中心 可用于诊断和治疗妊娠并发症的核酸和多肽
US20070111326A1 (en) * 2005-11-14 2007-05-17 Abbott Laboratories Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia
AU2006319138B2 (en) * 2005-11-30 2013-05-16 Mosaiques Diagnostics And Therapeutics Ag Polypeptide marker for the diagnosis and evaluation of vascular diseases
WO2007084486A2 (en) * 2006-01-13 2007-07-26 Battelle Memorial Institute Animal model for assessing copd-related diseases
GB0600916D0 (en) * 2006-01-17 2006-02-22 Perkinelmer Instr Las Inc detecting and predicting pre-eclampsia
US20090286271A1 (en) * 2006-05-31 2009-11-19 Karumanchi Ananth S Methods of Diagnosing and Treating Complications of Pregnancy
EP2030025A2 (en) * 2006-06-07 2009-03-04 Tethys Bioscience, Inc. Markers associated with arteriovascular events and methods of use thereof
US20080071151A1 (en) * 2006-06-30 2008-03-20 Sogin David C Method and Apparatus for Diagnosing Pre-eclampsia
AU2016208425A1 (en) * 2007-04-17 2016-08-18 Emd Millipore Corporation Graphical user interface for analysis and comparison of location-specific multiparameter data sets
WO2008131022A1 (en) * 2007-04-17 2008-10-30 Guava Technologies, Inc. Graphical user interface for analysis and comparison of location-specific multiparameter data sets
JP2009162616A (ja) * 2008-01-07 2009-07-23 Univ Of Tokyo オートタキシン測定による妊娠および妊娠高血圧症候群の検査方法および検査薬
CA2711071A1 (en) * 2008-01-07 2009-07-16 Ortho-Clinical Diagnostics, Inc. Determination of sflt-1:angiogenic factor complex
WO2009114591A1 (en) * 2008-03-11 2009-09-17 Smithkline Beecham Corporation Method and apparatus for screening drugs for predictors of quantitatively measured events
US8386187B2 (en) * 2008-10-20 2013-02-26 Liposcience, Inc. Lipoprotein insulin resistance indexes and related methods, systems and computer programs for generating same
EP2513653A1 (en) * 2009-10-09 2012-10-24 Carolyn Slupsky Methods for diagnosis, treatment and monitoring of patient health using metabolomics
GB201013151D0 (en) * 2010-08-04 2010-09-22 Isis Innovation Diagnostic method
US20140341880A1 (en) * 2011-09-15 2014-11-20 Nationwide Children's Hospital, Inc. Risk predictors for adverse perinatal outcomes
EP2861989A4 (en) 2012-06-15 2016-03-02 Univ Wayne State BIOMARK TEST FOR PREDICTING OR EARLY IDENTIFICATION OF PRE-LAMPSY AND / OR HELLP SYNDROME
BR112014029233A8 (pt) * 2012-06-27 2019-01-29 Hoffmann La Roche método para diagnosticar se um indivíduo grávido não está em risco, usos de pelo menos um dos biomarcadores sfit-1, endoglina e pigf, dispositivo, kit, método de gestão de um indivíduo, sistema e método para estabelecer um auxílio
US20140141456A1 (en) * 2012-08-30 2014-05-22 Ansh Labs, LLC Papp-a2 as a marker for monitoring, predicting and diagnosing preeclampsia
WO2014144129A2 (en) * 2013-03-15 2014-09-18 Sera Prognostics, Inc. Biomarkers and methods for predicting preterm birth
WO2014143977A2 (en) * 2013-03-15 2014-09-18 Sera Prognostics, Inc. Biomarkers and methods for predicting preeclampsia
IL256399B (en) * 2015-06-19 2022-09-01 Sera Prognostics Inc Pairs of biomarkers for predicting premature birth
CA3032944A1 (en) * 2016-08-05 2018-02-08 Sera Prognostics, Inc. Biomarkers for predicting preterm birth in a pregnant female exposed to progestogens
CN106706928A (zh) * 2017-01-19 2017-05-24 深圳大学 一种妊娠期糖尿病的早期预测标志物及其检测方法
GR20170100034A (el) * 2017-01-27 2018-10-22 Αθανασιος Κωνσταντινου Αναγνωστοπουλος Η πρωτεϊνη c9jv37 ως δεικτης για την προγνωση και διαγνωση της προεκλαμψιας κατα την διαρκεια της κυησης
EP3668996A4 (en) 2017-08-18 2021-04-21 Sera Prognostics, Inc. CLOCK PREGNANCY PROTEIN FOR PREDICTING THE DATE AND TIME TO BIRTH
JP2019041754A (ja) * 2017-08-31 2019-03-22 株式会社Ｎｔｔドコモ 予測装置及び予測方法
WO2019246577A1 (en) 2018-06-22 2019-12-26 Mayo Foundation For Medical Education And Research Methods and materials for improving arteriovenous fistula maturation and maintaining arteriovenous fistula functionality
JP7097570B2 (ja) * 2018-08-27 2022-07-08 株式会社Ｎｔｔドコモ データ収集解析装置及びデータ収集解析方法
US20220328185A1 (en) * 2019-05-24 2022-10-13 Yeda Research And Development Co. Ltd. Method and system for predicting gestational diabetes
CN110305970B (zh) * 2019-07-19 2022-10-04 广州市达瑞生物技术股份有限公司 一种基于外周血游离dna检测的巨大儿预测模型
EP4014040A4 (en) * 2019-08-15 2023-12-27 Mayo Foundation for Medical Education and Research METHODS AND MATERIALS FOR ASSESSMENT AND TREATMENT OF HYPERTENSIVE DISEASES
EP4070113A4 (en) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. ASSESSMENT OF PREECAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR ASSAYS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543138A (en) * 1994-03-10 1996-08-06 Genetics Institute, Inc. Methods of diagnosing and treating preeclampsia
EP0951298A1 (en) 1996-12-23 1999-10-27 Cambridge University Technical Services Limited Diagnosis and treatment of pathological pregnancies
WO1998040747A1 (en) * 1997-03-07 1998-09-17 Mount Sinai Hospital Corporation Methods to diagnose a required regulation of trophoblast invasion
WO2000052204A2 (en) * 1999-02-22 2000-09-08 Orntoft Torben F Gene expression in bladder tumors
US6461830B1 (en) * 2000-06-01 2002-10-08 Atairgin Technologies, Inc. Determining existence of preeclampsia in pregnancies by measuring levels of glycerophosphatidyl compounds, glycerophosphatidycholine, lysophospholipids and lysophosphatidylcholine
US20020102530A1 (en) * 2000-07-07 2002-08-01 Keith James C. Methods and compositions for diagnosing and treating preeclampsia and gestational trophoblast disorders
US20030175253A1 (en) * 2001-11-09 2003-09-18 Huda Akil Compositions and methods for diagnosing and treating mental disorders

Also Published As

Publication number Publication date
CA2539430A1 (en) 2005-04-07
EP1664797B1 (en) 2015-11-11
AU2004276791A1 (en) 2005-04-07
AU2004276791B2 (en) 2010-07-01
CA2539430C (en) 2015-03-17
US7344892B2 (en) 2008-03-18
ES2556164T3 (es) 2016-01-13
WO2005031364A1 (en) 2005-04-07
JP4568282B2 (ja) 2010-10-27
JP2007506979A (ja) 2007-03-22
US20080213794A1 (en) 2008-09-04
US20050148040A1 (en) 2005-07-07
EP1664797A1 (en) 2006-06-07

Similar Documents

Publication Publication Date Title
HK1092871A1 (zh) 先兆子癇的篩查
TWI372050B (en) (morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
GB0304799D0 (en) Novel method
EP1743945A4 (en) SCREENING METHOD
GB0310841D0 (en) Block
GB0309397D0 (en) Screening methods
EP1675596A4 (en) METHOD
EP1721971A4 (en) SCREENING PROCESS
EP1732394A4 (en) DEHYDRATION-GRIDING PROCESS
GB0301117D0 (en) Method
GB0304993D0 (en) Novel screening method
SG112083A1 (en) Method for screening autoantigen
EP1669446A4 (en) SCREENING PROCESS
GB2418286B (en) Disk-body sorter
GB0307329D0 (en) Method
EP1593416A4 (en) BLOCK
GB0304632D0 (en) Method
EP1612264A4 (en) ORGAN MOLDING
EP1694837A4 (en) METHOD
GB0320771D0 (en) Method for screening
GB0308890D0 (en) Screening method
GB0302700D0 (en) Screening method
GB0303536D0 (en) Method
HU0302804D0 (en) Round-sewing-machine for haemorrhoidectomy
HU0303705D0 (en) Round-sewing-machine for haemorr hoidectomy

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230923